Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xuesaitong Soft Capsules for Blood Stasis Syndrome in Coronary Heart Disease
NCT01615003Phase 2Unknown
- Sponsor
- Guang'anmen Hospital
- Start
- May 2012
- Primary completion
- Jul 2014
- Modality
- PE (Plant Extract)
- Countries
- 1
01
Overview
Phase 2, randomised trial of xuesetong capsule in coronary heart disease (CHD), unstable angina and blood stasis syndrome (BSS) (2 arms), sponsored by Guang'anmen Hospital. Primary endpoint: Change of Cycle threshold of relational microRNA at 1 month. Status: unknown.
02
Drugs
xuesetong capsule
03
Conditions
coronary heart disease (CHD)unstable anginablood stasis syndrome (BSS)
Beyond the preview
Go deeper on NCT01615003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01615003.